FDA Communications In Flux As HHS Assesses Mission-Critical Activities

 
• By Sue Sutter and Derrick Gingery
  
Wooden puzzle with question marks
The FDA is determining the activities it can communicate about to the public as it navigates limits imposed by the Trump Administration. (Shutterstock)

More from US FDA

More from Agency Leadership